Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study ; volume:22 ; number:1 ; day:21 ; month:10 ; year:2022 ; pages:1-9 ; date:12.2022
BMC psychiatry ; 22, Heft 1 (21.10.2022), 1-9, 12.2022
- Creator
-
Kawakita, Yuta
Takeshima, Masahiro
Komatsu, Tomonari
Imanishi, Aya
Fujiwara, Dai
Itoh, Yu
Mishima, Kazuo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-022-04312-4
- URN
-
urn:nbn:de:101:1-2023010709323412870564
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kawakita, Yuta
- Takeshima, Masahiro
- Komatsu, Tomonari
- Imanishi, Aya
- Fujiwara, Dai
- Itoh, Yu
- Mishima, Kazuo
- SpringerLink (Online service)
Other Objects (12)
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
An international research agenda for clozapine-resistant schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
Polygenetic risk scores and phenotypic constellations of obsessive–compulsive disorder in clozapine-treated schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
An international research agenda for clozapine-resistant schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
Polygenetic risk scores and phenotypic constellations of obsessive–compulsive disorder in clozapine-treated schizophrenia
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
An international research agenda for clozapine-resistant schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia